Suppr超能文献

GRK5基因中的精氨酸-304-组氨酸替换通过减轻NF-κB介导的炎症反应来预防脓毒症进展。

Genetic Arg-304-His substitution in GRK5 protects against sepsis progression by alleviating NF-κB-mediated inflammation.

作者信息

Xu Mingwei, Shao Yiming, Lin Kaisheng, Liu Yuchun, Lin Yao, Lin Yingying, Yang Ruoxuan, Liu Lizhen, Yin Mingkang, Liao Shuanglin, Jiang Shaoru, He Junbing

机构信息

Jieyang Medical Research Center, Jieyang People's Hospital, Jieyang Affiliated Hospital of Sun Yat-sen University, Jieyang, Guangdong, PR China.

The Intensive Care Unit, The First Dongguan Affiliated Hospital of Guangdong Medical University, Dongguan, Guangdong, PR China; The Key Laboratory of Sepsis Translational Medicine, The Intensive Care Unit, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, PR China.

出版信息

Int Immunopharmacol. 2023 Feb;115:109629. doi: 10.1016/j.intimp.2022.109629. Epub 2022 Dec 28.

Abstract

BACKGROUND

Previous studies have demonstrated that G protein-coupled receptor kinase 5 (GRK5) exerts a pivotal regulatory effect on the inflammation associated with sepsis. The present study aimed to investigate the clinical association of GRK5 genetic variants with sepsis and to further explore the underlying genetic mechanisms involved in regulating sepsis-induced inflammatory responses and the pathogenesis of sepsis.

METHODS

This case-control study enrolled 1081 septic patients and 1147 matched controls for genotyping of GRK5 rs2230349 and rs2230345 polymorphisms. The effect of these genetic variants on GRK5-mediated inflammatory responses was analyzed in peripheral blood mononuclear cells (PBMCs) and THP-1 macrophages. A clinically relevant polymicrobial sepsis model was established by subjecting wild-type (WT) and GRK5-knockout mice to cecal ligation and puncture (CLP) to evaluate the role of GRK5 in sepsis.

RESULTS

We identified significant differences in the genotype/allele distribution of rs2230349 G > A, but not rs2230345, between the sepsis subtype and septic shock subgroups (GA + AA vs. GG genotype, OR = 0.698, 95% CI = 0.547-0.893, P = 0.004; A vs. G allele, OR = 0.753, 95% CI = 0.620-0.919, P = 0.005) and between the survivor and nonsurvivor subgroups (GA + AA vs. GG genotype, OR = 0.702, 95% CI = 0.531-0.929, P = 0.015; A vs. G allele, OR = 0.753, 95% CI = 0.298-0.949, P = 0.017). PBMCs carrying the sepsis-associated protective A allele produced significantly lower levels of TNF-α and IL-1β upon LPS stimulation. The results from the in vitro experiment showed that the Arg-304-His substitution caused by the rs2230349 G-to-A mutation in GRK5 significantly decreased the LPS-induced production of several proinflammatory cytokines, such as TNF-α, IL-6, IL-1β and MCP-1, via the IκB-α/NF-κB signaling pathway in THP-1 macrophages. Furthermore, GRK5-knockout mice exhibited a significant decrease in IκB-α phosphorylation/degradation, the p-p65/p65 ratio, the p-p50/p50 ratio, p65 nuclear translocation and downstream cytokine (TNF-α, IL-6, IL-1β and VCAM-1) production compared to WT mice after CLP surgery. A significant improvement in 7-day survival rate in GRK5-KO septic mice was observed in the presence of antibiotics.

CONCLUSIONS

The Arg-304-His substitution caused by the rs2230349 G-to-A mutation in GRK5 might disrupt GRK5 function and alleviate IKB-α/NF-κB-mediated inflammatory responses, which ultimately conferred a genetic protective effect against susceptibility to sepsis progression and mortality. These results may, to some extent, explain the heterogeneity of the clinical prognoses of septic patients and provide novel opportunities for individualized approaches for sepsis treatment.

摘要

背景

先前的研究表明,G蛋白偶联受体激酶5(GRK5)对脓毒症相关炎症发挥关键调节作用。本研究旨在探讨GRK5基因变异与脓毒症的临床关联,并进一步探究调节脓毒症诱导的炎症反应及脓毒症发病机制的潜在遗传机制。

方法

本病例对照研究纳入了1081例脓毒症患者和1147例匹配的对照,对GRK5基因的rs2230349和rs2230345多态性进行基因分型。在人外周血单核细胞(PBMCs)和THP-1巨噬细胞中分析这些基因变异对GRK5介导的炎症反应的影响。通过对野生型(WT)和GRK5基因敲除小鼠进行盲肠结扎和穿刺(CLP)建立临床相关的多微生物脓毒症模型,以评估GRK5在脓毒症中的作用。

结果

我们发现,在脓毒症亚型和感染性休克亚组之间,rs2230349基因G>A的基因型/等位基因分布存在显著差异,而rs2230345不存在差异(GA+AA与GG基因型相比,OR=0.698,95%CI=0.547-0.893,P=0.004;A与G等位基因相比,OR=0.753,95%CI=0.620-0.919,P=0.005),在存活者和非存活者亚组之间也存在显著差异(GA+AA与GG基因型相比,OR=0.702,95%CI=0.531-0.929,P=0.015;A与G等位基因相比,OR=0.753,95%CI=0.298-0.949,P=0.017)。携带脓毒症相关保护性A等位基因的PBMCs在脂多糖(LPS)刺激下产生的肿瘤坏死因子-α(TNF-α)和白细胞介素-1β(IL-1β)水平显著降低。体外实验结果表明,GRK5基因rs2230349位点G突变为A所导致的第304位精氨酸突变为组氨酸,显著降低了LPS诱导的多种促炎细胞因子(如TNF-α、IL-6、IL-1β和单核细胞趋化蛋白-1(MCP-1))在THP-1巨噬细胞中的产生,这一过程通过IκB-α/核因子κB(NF-κB)信号通路介导。此外,与CLP手术后的WT小鼠相比,GRK5基因敲除小鼠的IκB-α磷酸化/降解、p-p65/p65比值、p-p50/p50比值、p65核转位及下游细胞因子(TNF-α、IL-6、IL-1β和血管细胞黏附分子-1(VCAM-1))产生均显著降低。在使用抗生素的情况下,观察到GRK5基因敲除的脓毒症小鼠7天存活率有显著提高。

结论

GRK5基因rs2230349位点G突变为A所导致的第304位精氨酸突变为组氨酸可能破坏GRK5功能,减轻IκB-α/NF-κB介导的炎症反应,最终赋予对脓毒症进展和死亡易感性的遗传保护作用。这些结果在一定程度上可能解释脓毒症患者临床预后的异质性,并为脓毒症的个体化治疗提供新的契机。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验